Anika Therapeutics (ANIK) Current Assets (2010 - 2026)
Anika Therapeutics (ANIK) posted quarterly Current Assets of $99.2 million for Q2 2026, little changed year-over-year from $99.3 million in Q2 2025, and up 6.02% quarter-over-quarter from $93.6 million in Q1 2026.
Anika Therapeutics (ANIK) Current Assets (2010 - 2026) Analysis & Trends
Anika Therapeutics (ANIK) has reported Current Assets for 17 consecutive years, with $99.2 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Current Assets changed 0.13% year-over-year to $99.2 million; the TTM figure through Jun 2026 stood at $99.2 million (changed 0.13% YoY), while the FY2025 annual figure was $103.4 million, down 9.06% from the prior year.
- Current Assets improved to $99.2 million in Q2 2026 per ANIK's latest filing, from $93.6 million in the prior quarter.
- Across five years, Current Assets topped out at $169.5 million in Q4 2022 and bottomed at $93.6 million in Q1 2026.
- Historically, Current Assets has averaged $137.0 million across 5 years, with a median of $153.6 million in 2023.
- Annual changes were most pronounced in 2024 — Current Assets grew 1.84% — and 2025, when it slumped 35.92%.
- Anika Therapeutics' Current Assets stood at $169.5 million in 2022, then retreated by 3.68% to $163.3 million in 2023, then sank by 30.41% to $113.7 million in 2024, then declined by 9.06% to $103.4 million in 2025, then dropped by 4.03% to $99.2 million in 2026.
- Business Quant data shows ANIK's Current Assets at $99.2 million in Q2 2026, $93.6 million in Q1 2026, and $103.4 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | 5.76 Bn |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn | 13.76 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | 6.36 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 19.76 Bn |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn | 3.48 Bn |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn | 10.06 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 1.64 Bn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 3.80 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | 3.22 Bn |
| 10 | Anika Therapeutics | 283.60 Mn | 245.18 Mn | 21.24 Mn | 99.19 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 99.19 Mn |
| Mar 31, 2026 | 93.56 Mn |
| Dec 31, 2025 | 103.36 Mn |
| Sep 30, 2025 | 101.59 Mn |
| Jun 30, 2025 | 99.32 Mn |
| Mar 31, 2025 | 102.51 Mn |
| Dec 31, 2024 | 113.65 Mn |
| Sep 30, 2024 | 136.11 Mn |
| Jun 30, 2024 | 155.00 Mn |
| Mar 31, 2024 | 158.96 Mn |
| Dec 31, 2023 | 163.31 Mn |
| Sep 30, 2023 | 156.78 Mn |
| Jun 30, 2023 | 152.20 Mn |
| Mar 31, 2023 | 160.33 Mn |
| Dec 31, 2022 | 169.55 Mn |
| Sep 30, 2022 | 167.76 Mn |
| Jun 30, 2022 | 167.86 Mn |
| Mar 31, 2022 | 165.32 Mn |
| Dec 31, 2021 | 168.53 Mn |
| Sep 30, 2021 | 165.78 Mn |